FDA approves Pfizer booster for elderly, others at high risk
The United States Food and Drug Administration has authorised the use of boosters of Pfizer’s COVID-19 vaccine for people aged over 65, as well as adults at high risk of severe disease and those in high-exposure jobs.
READ ALSO: …